PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg 58€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg 147€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  5. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  6. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  7. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  8. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  9. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  10. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  11. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  12. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  13. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  14. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  15. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  16. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  17. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  18. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  19. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  20. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  21. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  22. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  23. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  24. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  25. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  26. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  27. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  28. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  29. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  30. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  31. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  32. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  33. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  34. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  35. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  36. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  37. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  38. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  39. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  40. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  41. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  42. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  43. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  44. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  45. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  46. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  47. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  48. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  49. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  50. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  51. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  52. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  53. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  54. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  55. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  56. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  57. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  58. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  59. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  60. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  61. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  62. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  63. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  64. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  65. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  66. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  67. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  68. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  69. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  70. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  71. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  72. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  73. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  74. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  75. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  76. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  77. Vorselen D, et al. 2021. Elife. 10:. PubMed
  78. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  79. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  80. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  81. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  82. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  83. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  84. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  85. De Simone G, et al. 2021. Immunity. :. PubMed
  86. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  87. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  88. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  89. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  90. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  91. Koikawa K, et al. 2021. Cell. 184(18):4753-4771.e27. PubMed
  92. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  93. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  94. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  95. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  96. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  97. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  98. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  99. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  100. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  101. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  102. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  103. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  104. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  105. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  106. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  107. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  108. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  109. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  110. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  111. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  112. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  113. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  114. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  115. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  116. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  117. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  118. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  119. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  120. Gu H, et al. 2021. Elife. 10:. PubMed
  121. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  122. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  123. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  124. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  125. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  126. Bussey KA, et al. 2019. J Virol. 93. PubMed
  127. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  128. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  129. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  130. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  131. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  132. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  133. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  134. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  135. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  136. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  137. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  138. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
  139. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  140. Jones GS, et al. 2020. mSphere. 5:. PubMed
  141. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  142. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  143. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  144. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  145. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  146. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  147. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  148. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  149. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  150. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  151. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  152. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  153. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  154. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  155. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  156. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  157. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  158. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  159. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  160. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC, IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC, CyTOF®, IP, IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC, IHC, ICC, 3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC, IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC, CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F, 3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD11c

  • Biotin anti-mouse CD11c

  • FITC anti-mouse CD11c

  • PE anti-mouse CD11c

  • Purified anti-mouse CD11c

  • Alexa Fluor® 488 anti-mouse CD11c

  • Alexa Fluor® 647 anti-mouse CD11c

  • PE/Cyanine5 anti-mouse CD11c

  • PE/Cyanine7 anti-mouse CD11c

  • Brilliant Violet 605™ anti-mouse CD11c

  • Alexa Fluor® 700 anti-mouse CD11c

  • Pacific Blue™ anti-mouse CD11c

  • APC/Cyanine7 anti-mouse CD11c

  • PerCP/Cyanine5.5 anti-mouse CD11c

  • PerCP anti-mouse CD11c

  • Brilliant Violet 421™ anti-mouse CD11c

  • Brilliant Violet 570™ anti-mouse CD11c

  • Brilliant Violet 785™ anti-mouse CD11c

  • Brilliant Violet 510™ anti-mouse CD11c

  • Brilliant Violet 650™ anti-mouse CD11c

  • Purified anti-mouse CD11c (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD11c

  • PE/Dazzle™ 594 anti-mouse CD11c

  • Brilliant Violet 711™ anti-mouse CD11c

  • APC/Fire™ 750 anti-mouse CD11c

  • TotalSeq™-A0106 anti-mouse CD11c

  • Brilliant Violet 750™ anti-mouse CD11c

  • TotalSeq™-B0106 anti-mouse CD11c

  • TotalSeq™-C0106 anti-mouse CD11c

  • KIRAVIA Blue 520™ anti-mouse CD11c

  • Spark Blue™ 550 anti-mouse CD11c

  • Spark NIR™ 685 anti-mouse CD11c

  • Spark UV™ 387 anti-mouse CD11c

  • Spark Red™ 718 anti-mouse CD11c

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account